Zhonghong Pulin Medical Products Co., Ltd. Class A 300981

SZSE · China · Consumer Non-Durables

CNY 20.30+2.40 (+13.41%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Zhonghong Pulin Medical Products Co., Ltd. Class A 300981

SZSE · China · Consumer Non-Durables

CNY 20.30+2.40 (+13.41%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+50.48% · 6MFull-screen chart

Open CNY 18.01High CNY 21.46Low CNY 17.90Close CNY 20.30Volume 37.32M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 17.90
Day range: CNY 17.90 – CNY 21.46
52-week range: CNY 9.21 – CNY 21.46
Volume: 37.32M
Market cap: CNY 8.71B
P/E (TTM): 225.6
Dividend yield (annualized): 1.72%
Avg. volume (1Y): 10.76M

Performance

1 week

+10.51%

1 month

+33.03%

3 months

+100.99%

6 months

+46.53%

Year to date

+60.16%

1 year

+54.81%

Total return, dividends included.

Company profile

Sector: Consumer Non-Durables
Industry: Apparel/Footwear
Country: China
Exchange: SZSE
Shares outstanding: 427.29M
Employees: 3,884
ISIN: CNE100004KR0
Beta: 0.91

Technical view

Above averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceSep 21, 2026

Zhonghong Medical Reports H1 2026 Net Profit Surge of Over 26-Fold

Zhonghong Pulin Medical Products Co., Ltd.XIAMEN, China, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Zhonghong Pulin Medical Products Co., Ltd. ("Zhonghong Medical", 300981.SZ) recently disclosed its interim report for 2026. According to the report, the company achieved a revenue of RMB 1.478 billion in the first half of the year, representing a year-on-year growth of 19.46%. Net profit attributable to shareholders of the listed company reached RMB 159 million, marking a dramatic year-on-year surge of 2,

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.